CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

"And I, you know what I think that Dr. Bourla, he's done a lot of good worldwide. He's done many things that I think are very positive for healthcare. I think that the issue has been, what about ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Dr. Albert Bourla is also troubled by this trend — and few people are more personally connected to the topic. Bourla is the son of two Holocaust survivors, and he is the CEO and chairman of ...

(Reuters) -U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...

Dr. Albert Bourla, Pfizer (PFE) Chairman and CEO, stated: “Pfizer is in a strong position to continue making a positive impact for patients and delivering on our financial commitments in 2025.

Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer, stated: “Pfizer is in a strong position to continue making a positive impact for patients and delivering on our financial ...

We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim ...